En Carta Diagnostics

Seed
encarta.bio Biotech & Healthcare Paris, France
Total Funding $1.6M
Latest Round Undisclosed Seed
Last Announced Jul 10, 2026
Investors Undisclosed
Decision Makers 5 Verified

About En Carta Diagnostics

En Carta Diagnostics develops molecular diagnostic technologies that enable the detection of DNA and RNA pathogens at the point of care.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Paris, France
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website encarta.bio
Domain Registered Date Apr 18, 2020

Social & Network Presence

X / Twitter Profile @encartabio (12 followers) Created on Apr 2023
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Seed announced

  2. Capital Raise

    Raised $1,630,000 · Pre-Seed

    startupintros.com

  3. Milestone

    X account created (@encartabio)

    12 followers

  4. Milestone

    Website domain registered

    encarta.bio

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for En Carta Diagnostics.

Funding History

2 Rounds
Seed · Jul 10, 2026
Undisclosed
Pre-Seed · May 22, 2024

Founders & Leadership

2

Guillaume Horreard

Founder

Work email & phone locked Unlock →

Margot Karlikow

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts